Evaluation of poliovirus antibody titers in orally vaccinated semi-captive chimpanzees in Uganda

Journal of Medical Primatology

Volumn 39, Issue 2, 2010, Pages 123-128

  Mugisha, L ^a,b   Pauli, G ^c   Opuda Asibo, J ^b   Joseph, O O ^c   Leendertz, F H ^d   Diedrich, S ^d  

^a Chimpanzee Sanctuary and Wildlife Conservation Trust CSWCT   (Uganda)

^b MAKERERE UNIVERSITY   (Uganda)

^c Department of Microbiology   (Uganda)

^d ROBERT KOCH INSTITUTE   (Germany)

Author keywords

Chimpanzees; Great apes; Neutralizing antibodies; Poliomyelitis; Transmission

Indexed keywords

NEUTRALIZING ANTIBODY; ORAL POLIOMYELITIS VACCINE; SABIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; CHIMPANZEE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; IMMUNE RESPONSE; INFECTION RESISTANCE; MALE; NONHUMAN; POLIOMYELITIS; POLIOMYELITIS VIRUS; POLIOMYELITIS VIRUS 1; POLIOMYELITIS VIRUS 2; POLIOMYELITIS VIRUS 3; PRIORITY JOURNAL; UGANDA; VACCINATION; VIRUS STRAIN; VIRUS TRANSMISSION;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; APE DISEASES; FEMALE; MALE; NEUTRALIZATION TESTS; PAN TROGLODYTES; POLIOMYELITIS; POLIOVIRUS; POLIOVIRUS VACCINE, ORAL; UGANDA; VACCINATION;

HOMINIDAE; PAN; POLIOVIRUS;

EID: 77951658521     PISSN: 00472565     EISSN: 16000684     Source Type: Journal    
DOI: 10.1111/j.1600-0684.2010.00400.x     Document Type: Article

References (43)

1. Allmond BW, Froeschle JE, Guilloud NB. Paralytic poliomyelitis in large laboratory primates. Virological investigation and report on the use of oral poliomyelitis virus (OPV) vaccine. Am J Epidemiol 1967, 85:229-39.
2. Bodian D. Poliomyelitis. Pathology of the Nervous System 1972, 3:2323-44. Minckler In, Vol, ed, New York, McGraw-Hill
3. Bodian D, Morgan IM, Howe HA. Differentiation of types of poliomyelitis viruses. III. The grouping of fourteen strains into three basic immunological types. Am J Hyg 1949, 49:234-45.
4. Brack M. Agents Transmissible from Simians to Man 1987, Berlin, Springer-Verlag
5. Cherkasova E, Laassri M, Chizhikov V, Korotkova E, Dragunsky E, Agol IV, Chumakov K. Microarray analysis of evolution of RNA viruses: evidence of circulation of virulent highly divergent vaccine-derived polioviruses. PNAS 2003, 100:9398-403.
6. Circulation of a type 2 vaccine-derived poliovirus-Egypt, 1982-1993. Morb Mortal Wkly Rep 2001, 50:41-51.
7. Progress toward global eradication of poliomyelitis, 2001. Morb Mortal Wkly Rep 2002a, 51:253-6.
8. Conyn-van Spaendonck MA, de Melker HE, Abbink F, Elzinga-Gholizadea N, Kimman TG, Van Loon T. Immunity to poliomyelitis in Netherlands. Am J Epidemiol 2003, 153:207-14.
9. Diedrich S, Claus H, Schreier E. Immunity status against poliomyelitis in Germany: determination of cut-off values in International Units. BMC Infect Dis 2002, 2:1471-2334. http://www.biomedcentral.com/1471-2334/2/2
10. Douglas JD, Soike KF, Raynor J. The incidence of polio virus in chimpanzees (Pan troglodytes). Lab Anim Care 1970, 20:265-8.
11. Dowdle WR, Birmingham ME. The biologic principles of poliovirus eradication. J Infect Dis 1997, 175:S286-92.
12. Global advisory Group. Wkly Epidemiol Rec 1991, 66:3-12.
13. Gear JHS. The extra human sources of poliomyelitis. Poliomyelitis Papers and Discussions Presented at the Second International Poliomyelitis Conference 1952, In, Philadelphia, JB Lippincott
14. Goodall J, Van L. Behaviour of free-living chimpanzees of the Gombe Stream area. Anim Behav Monogr 1968, 1:163-311.
15. Goodall J. Population dynamics during a fifteen-year period in one community of free-living chimpanzees in the Gombe National Park, Tanzania. Z Tierpsychol 1983, 61:1-60.
16. Goodall J. The Chimpanzees of Gombe: Patterns of Behavior 1986, Cambridge, Massachusetts, Harvard University Press
17. Guilloud NB, Allmond BW, Froeschle JE, Fitz-Gerald FL. Paralytic poliomyelitis in laboratory primates. J Am Vet Med Assoc 1969, 155:1190-3.
18. Hovi T, Lindholm N, Savolainen C, Stenvik M, Burns C. Evolution of wild-type 1 poliovirus in two healthy siblings excreting the virus over a period of 6 months. J Gen Virol 2004, 85:369-77.
19. Hovi T, Blomqvist S, Nasr E, Burns CC, Sarjakoski T, Ahmed N, Savolainen C, Roivainen M, Stenvik M, Laine P, Barakat I, Wahdan MH, Kamel FA, Asghar H, Pallansch MA, Kew OM, Gary HE, deGourville EM, El Bassioni L. Environmental surveillance of wild poliovirus circulation in Egypt-balancing between detection sensitivity and workload. J Virol Methods 2005, 126:127-34.
20. Howe HA, Bodian D. Poliomyelitis by accidental contagion in the chimpanzee. J Exp Med 1944, 80:383-90.
21. Howe HA, Bodian D. Poliomyelitis in the cynomologus monkey following oral inoculation. Am J Hyg 1948, 48:99-106.
22. Huckster RL. Poliomyelitis. A Guide for Developing Countries-Including Appliances and Rehabilitation for the Disabled 1975, NewYork, Churchill Livingstone
23. John TJ, Jayabal R. Oral polio vaccination of children in the tropics: the poor seroconversion rates and the absence of viral interference. Am J Epidemiol 1972, 96:263-9.
24. Juhela S, Hyöty H, Uibo R, Meriste SH, Lönnrot M, Halminen M, Simell O, Ilonen J. Comparison of enterovirus-specific cellular immunity in two populations of young children vaccinated with inactivated or live poliovirus vaccines. Clin Exp Immunol 1999, 117:100-5.
25. Junge RE. Vaccination Programs: Preventive Medicine Recommendations 1995, American Association of Zoo Veterinarians Infectious Disease Committee, St. Louis, Missouri
26. Kew OM, Wright PF, Agol VI, Delpeyroux F, Shimizu H, Nathanson N, Pallansch M. Circulating vaccine-derived polioviruses: current state of knowledge. Bull World Health Organ 2004, 82:16-32.
27. Kortlandt A. An epidemic of limb paresis (polio) among the chimpanzee population at Beni (Zaire) in 1964, possibly transmitted by humans. Pan Afr News 1996, 3:2.
28. Leendertz FH, Pauli G, Maetz-Rensing K, Boardman W, Nunn C, Ellerbrok H, Jensen SA, Junglen S, Boesch C. Pathogens as drivers of population declines: the importance of systematic monitoring in great apes and other threatened mammals. Biol Conserv 2006, 131:325-37.
29. Martin J. Vaccine-derived poliovirus from long term excretors and the end game of polio eradication. Biologicals 2006, 34:117-22.
30. Melnick JL. Current status of polio infections. Clin Microbiol Rev 1996, 9:293-300.
31. Morbeck ME, Zihlman AL, Sumner DR, Galloway A. Poliomyelitis and skeletal asymmetry in Gombe Chimpanzees. Primates 1991, 32:77-91.
32. Moriniere BJ, van Loon FP, Rhodes PH, Klein-Zabban ML, Frank-Senat B, Herrington JE, Patriarca PA. Immunogenicity of a supplemental dose of oral versus inactivated poliovirus vaccine. Lancet 1993, 341:1545-50.
33. Nathanson N, Martin JR. The epidemiology of poliomyelitis: enigmas surrounding its appearance, epidemiology, and disappearance. Am J Epidemiol 1979, 110:672-91.
34. Oduntan SO, Lucas AO, Wennen EM. The immunological response of Nigerian infants to attenuated and inactivated polio vaccines. Ann Trop Med Parasitol 1978, 72:111-5.
35. Pelczar MJ, Chan ECS, Krieg NR. Microbiology: Concepts and Applications 1993, McGraw-Hill, Inc, New York
36. Samuel BU, Ponnuraj E, Rajasingh J, John TJ. Experimental poliomyelitis in bonnet monkey. Clinical features, virology and pathology. Dev Biol Stand 1993, 78:71-8.
37. Teleki G, Hunt EE, Pfifferling JH. Demographic observations (1963-1973) on chimpanzees of Gombe National Park, Tanzania. J Human Evol 1976, 5:559-98.
38. Wallis J, Lee DR. Primate conservation: the prevention of disease transmission. Int J Primatol 1999, 20:803-26.
39. Wood DJ, Sutter RW, Dowdle WR. Stopping poliovirus vaccination after eradication: issues and challenges. Bull World Health Organ 2000, 78:347-57.
40. Woodford MH. Quarantine and Health Screening Protocols for Wildlife prior to Translocation and Release into the Wild 2000, Ed, IUCN Species Survival Commission's Veterinary Specialist Group, Gland, Switzerland, the Office International des Epizooties (OIE), Paris, France, Care for the Wild, U.K., and the European Association of Zoo and Wildlife Veterinarians, Switzerland
41. Polio Laboratory Manual 4th edn, ). WHO/IVB/04.10, 2004
42. Global eradication of poliomyelitis by the year 2000. Resolution 41-28 of the 41st World Health Assembly 1998, In, Geneva, Switzerland, World Health Organization
43. WHO global action plan for laboratory containment of wild polioviruses. Second edition revised in 2004 and 2008 2003, Geneva, Department of Vaccines and Biologicals. World Health Organization, WHO/V&B/03.11